Autonomous Growth of Committed Hematopoietic Progenitors from Peripheral Blood of Workers Exposed to Low Levels of Benzene

Journal of Occupational and Environmental Medicine

Volumn 46, Issue 1, 2004, Pages 27-29

  Quitt, Miriam ^a   Cassel, Aliza ^a   Yoffe, Anatol ^a   Anatol, Anna Maria ^b,c   Froom, Paul ^a  

^a CARMEL MEDICAL CENTER   (Israel)

^b General Health Services   (Israel)

^c Lady Davis Carmel Medical Center ^*

Author keywords

[No Author keywords available]

Indexed keywords

BENZENE;

ADULT; ARTICLE; CELL GROWTH; CLINICAL ARTICLE; COLONY FORMING UNIT GM; CONTROLLED STUDY; ERYTHROID CELL; GRANULOCYTE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MALE; MONOCYTE; MYELOPROLIFERATIVE DISORDER; OCCUPATIONAL EXPOSURE; SMOKING;

ADULT; BENZENE; ERYTHROID PROGENITOR CELLS; HEMATOPOIESIS; HUMANS; MALE; MYELOPROLIFERATIVE DISORDERS; OCCUPATIONAL EXPOSURE; PETROLEUM;

EID: 0347717680     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jom.0000106009.06837.38     Document Type: Article

References (13)

1. Goldstein BD. Benzene toxicity. Occupational Medicine: State of the Art Reviews. 1988;3:541-553.
2. Hazel BA, O'Connor A, Niculescu R, et al. Benzene and its metabolite, hydroquinone, induce granulocyte differentiation in myeloblasts by interacting with cellular signaling pathways activated by granulocyte colony-stimulating factor. Stem Cells. 1995;13:295-310.
3. Hazel BA, Baum C, Kalf GF. Hydroquinone, a bioreactive metabolite of benzene, inhibits apoptosis in myeloblasts. Stem Cells. 1996;14:730-742.
4. Peretz C, Froom P, Pardo A, et al. Exposure to benzene in fuel distribution installations: monitoring and prevention. Arch Environ Health. 2000;55:439-446.
5. Dempster AM, Snyder CA. Short term benzene exposure provides a growth advantage for granulopoietic progenitor cells over erythroid progenitor cells. Arch Toxicol. 1990;64:539-544.
6. Froom P, Dyerassi L, Cassel A, et al. Erythropoietin-independent colonies of red blood cells and leukocytosis in a worker exposed to low levels of benzene. Scand J Work Environ Health. 1994;20:306-308.
7. Abraham NG. Hematopoietic effects of benzene inhalation assessed by long-term bone marrow culture. Environ Health Perspect. 1996;104(suppl 6):1277-1282.
8. Bergsagel D, Wong O, Bergsagel PL, et al. Benzene and multiple myeloma: appraisal of the scientific evidence. Blood. 1999;94:1174-1182.
9. Pearson TC. Evaluation of diagnostic criteria in polycythemia vera. Semin Hematol. 2001;38:21-24.
10. Westwood NB, Pearson TC. Diagnostic applications of haemopoietic progenitor culture techniques in polycythaemias and thrombocythaemias. Leuk Lymphoma. 1996;22(suppl 1):95-103.
11. Lynge E, Anttila A, Hemminki K. Organic solvents and cancer. Cancer Causes Control. 1997;8:406-419.
12. Schnatter AR, Armstrong TW, Nicolich MJ, et al. Lymphohaematopoietic malignancies and quantitative estimates of exposure to benzene in Canadian petroleum distribution workers. Occup Environ Med. 1996;53:773-781.
13. Paxton MB, Clinchilli VM, Brett SM, et al. Leukemia risk-associated with benzene exposure in the Pliofilm cohort. II. Risk Estimates Risk Anal. 1994;14:155-161.